C.H. ROBINSON WORLDWIDE, INC.

CHRW

CIK 0001043277 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$3.91B
↓-6.5% -$272Mvs FY2024 (Q4)
Operating Income
$181M
↓-1.3% -$2Mvs FY2024 (Q4)
Net Income
$136M
↓-8.7% -$13Mvs FY2024 (Q4)
Gross Profit
$3.91B
↓-6.5% -$272Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
62/100
  • Profitability
    82ROIC 21.4% (10% = solid, 20%+ = moat)
  • Liquidity
    51Current Ratio 1.53 (above 1.5 = solid)
  • Leverage
    70D/E 0.59 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 3.13x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -6.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    68Op Margin 4.6% · trend +1.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CHRW's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -17.4%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$102.82
Total enterprise IV
$12.49B
Diluted shares
0.12B
Terminal PV
$8.80B (70% of total)
Year-5 FCF
$1.04B
YearProjected FCFDiscounted PV
+1$922M$838M
+2$949M$785M
+3$978M$735M
+4$1.01B$688M
+5$1.04B$644M
Terminal$14.18B$8.80B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$20M
investment in PP&E
Dividends paid (TTM)
$301M
cash returned to holders
Stock buybacks (TTM)
$355M
share count reduction
Stock-based comp (TTM)
$80M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$5.06B
everything owned
Total liabilities
$3.21B
everything owed
Stockholders' equity
$1.85B
shareholder claim
Net debt
$929M
LT debt minus cash

Recent performance · 72 quarters

Revenue↓-6.5% -$272M
$3.91B
Net Income↓-8.7% -$13M
$136M
Free Cash Flow↑+14.0% +$37M
$302M
Operating Margin↑+0.2pts
4.6%

Drill down